Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Amneal Pharmaceuticals, Inc. Transaction History
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
- $3.65 Billion
- Q4 2024
A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 46,240 shares of AMRX stock, worth $362,059. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,240
Previous 40,717
13.56%
Holding current value
$362,059
Previous $338,000
8.28%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
123MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$116 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$96.5 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$88.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$84 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$70.3 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.19B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...